Notification - buyback 16 - 20 January 2023

No. 4 / 23 January 2023

To: BUCHAREST STOCK EXCHANGE

       FINANCIAL SUPERVISORY AUTHORITY

CURRENT REPORT

Current report drafted according to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations

Report Date: 23 January 2023

Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania

Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: 33,217,623 RON

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

In accordance with ASF Regulation no. 5/2018 and art. 2 of the Commission Delegated Regulation (EU) 1052/2016, MED LIFE S.A. reports to the regulated market the following transactions performed for M symbol during 16 – 20 January 2023:

Intermediary of transactions: BT Capital Partners S.A.

Reason for the notification of transactions: the buy-back of its own ordinary shares in accordance with EGSM Decision no. 2 from 29 September 2021.

Summary of transactions during 16 – 20 January 2023:

Detailed transactions for the period 16 – 20 January 2023:

No shares buy-back transactions were performed during 16 – 20 January 2023.

________________

Mihail Marcu

Chief Executive Officer